XML 21 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $ 175,803,000 $ 30,561,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Gain on sale of investment properties (119,761,000) (13,944,000)
Depreciation and amortization, including discontinued operations 104,924,000 64,350,000
Amortization of deferred financing costs and premium/discount on notes payable (2,948,000) 699,000
Stock-based compensation expense, net of forfeitures 1,979,000 1,153,000
Effect of certain non-cash adjustments to rental revenues (24,057,000) (9,656,000)
Income from unconsolidated joint ventures (40,901,000) (3,618,000)
Operating distributions from unconsolidated joint ventures 39,982,000 4,209,000
Gain on extinguishment of debt (1,829,000) 0
Changes in other operating assets and liabilities:    
Change in other receivables and other assets, net 3,108,000 (5,188,000)
Change in operating liabilities (10,063,000) (8,472,000)
Net cash provided by operating activities 126,237,000 60,094,000
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from investment property sales 167,118,000 21,088,000
Property acquisition, development, and tenant asset expenditures (151,150,000) (75,594,000)
Purchase of tenant in common interest (13,382,000) 0
Collection of notes receivable 5,161,000 0
Investment in unconsolidated joint ventures (8,266,000) (22,281,000)
Distributions from unconsolidated joint ventures 40,939,000 4,099,000
Change in restricted cash 7,495,000 (876,000)
Net cash provided by (used in) investing activities 47,915,000 (73,564,000)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from credit facility 457,000,000 163,700,000
Repayment of credit facility (497,000,000) (100,700,000)
Proceeds from issuance of notes payable 100,000,000 0
Repayment of notes payable (413,726,000) (4,589,000)
Payment of deferred financing costs (2,030,000) 0
Shares withheld for payment of taxes on restricted stock vesting (701,000) 0
Common stock issued, net of expenses 211,820,000 0
Contributions from noncontrolling interests 900,000 1,473,000
Distributions to nonredeemable noncontrolling interests (966,000) 0
Repurchase of common stock 0 (13,743,000)
Common dividends paid (48,815,000) (33,728,000)
Other 99,000 0
Net cash provided by (used in) financing activities (193,419,000) 12,413,000
NET DECREASE IN CASH AND CASH EQUIVALENTS (19,267,000) (1,057,000)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 35,687,000 2,003,000
CASH AND CASH EQUIVALENTS AT END OF PERIOD 16,420,000 946,000
Interest paid, net of amounts capitalized 22,721,000 14,131,000
Significant non-cash transactions:    
Transfer from investment in unconsolidated joint ventures to operating properties 68,390,000 0
Transfer from projects under development to operating properties 58,928,000 0
Common stock dividends declared 25,212,000 0
Transfer from investment in unconsolidated joint ventures to projects under development 0 5,880,000
Change in accrued property acquisition, development, and tenant asset expenditures $ (1,110,000) $ 3,891,000